Zentek Ltd. — Investor Relations & Filings
Zentek Ltd. is an intellectual property (IP) development and commercialization company specializing in nanotechnology. It leverages expertise in nanomaterials, particularly graphene, to research, develop, and patent advanced solutions for the healthcare, safety, and environmental sectors. The company's primary focus is on creating technologies for prevention, detection, and treatment. Its flagship commercial product is ZenGUARD™, a proprietary graphene-based antimicrobial coating that enhances the pathogen-filtering efficacy of personal protective equipment like surgical masks. Zentek's development pipeline also includes other advanced materials, such as graphite-based fire-retardant products, which it advances toward commercialization through strategic partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2026-05-27 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-13 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-06 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-28 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-22 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-16 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 47718185 | FORM 6-K | 2026-05-27 | English | ||
| 45626550 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-13 | English | ||
| 41929009 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-06 | English | ||
| 38023632 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-28 | English | ||
| 35277900 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-22 | English | ||
| 34650021 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-16 | English | ||
| 34596920 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-15 | English | ||
| 34417504 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-13 | English | ||
| 33135818 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-01 | English | ||
| 33040816 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-03-25 | English | ||
| 32199603 | 6-K Filing | 2026-01-29 | English | ||
|
2025
4 filings
| |||||
| 13569824 | FORM 6-K | 2025-12-17 | English | ||
| 13569823 | FORM 6-K | 2025-11-25 | English | ||
| 13569826 | FORM 6-K | 2025-11-21 | English | ||
| 13569829 | FORM 6-K | 2025-11-14 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMUGENE LIMITED
Clinical-stage immuno-oncology company developing cancer im…
|
IMU | AU | Professional, scientific and te… |
|
IMV Inc.
Pioneering novel immunotherapies using the proprietary DPX®…
|
IMV | CA | Professional, scientific and te… |
|
INBIOGEN CO.,Ltd
A life sciences firm offering bioinformatics and data minin…
|
101140 | KR | Professional, scientific and te… |
|
Incannex Healthcare Inc.
A clinical-stage biopharma firm developing cannabinoid and …
|
IXHL | US | Professional, scientific and te… |
|
Indaptus Therapeutics, Inc.
Develops bacterial-based immunotherapies for cancer and vir…
|
INDP | US | Professional, scientific and te… |
|
InflaRx N.V.
Clinical-stage biopharmaceutical firm developing C5a/C5aR p…
|
IFRX | NL | Professional, scientific and te… |
|
Inhalation Sciences Sweden AB
Develops lab instruments and provides research for preclini…
|
ISAB | SE | Professional, scientific and te… |
|
Initiator Pharma A/S
Clinical-stage company developing drugs for central and per…
|
INIT | DK | Professional, scientific and te… |
|
Inmolecule Nanotech, S.A.
Develops nanoparticles from plant compounds for biomedical …
|
MLINA | ES | Professional, scientific and te… |
|
InNexus Biotechnology Inc.
Develops enhanced monoclonal antibodies and diagnostics usi…
|
IXSBF | CA | Professional, scientific and te… |
Zentek Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34277/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34277 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34277 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34277 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34277}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zentek Ltd. (id: 34277)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.